Literature DB >> 15078832

Drug therapy for autonomic dysreflexia.

Hubert A Anton, Andrea Townson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15078832      PMCID： PMC385336          DOI： 10.1503/cmaj.1031913

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  3 in total

1.  Evaluation of captopril for the management of hypertension in autonomic dysreflexia: a pilot study.

Authors:  Zahida Esmail; Karen F Shalansky; Rubina Sunderji; Hugh Anton; Keith Chambers; William Fish
Journal:  Arch Phys Med Rehabil       Date:  2002-05       Impact factor: 3.966

2.  The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure.

Authors: 
Journal:  Arch Intern Med       Date:  1997-11-24

Review 3.  Rehabilitation medicine: 1. Autonomic dysreflexia.

Authors:  Jeff Blackmer
Journal:  CMAJ       Date:  2003-10-28       Impact factor: 8.262
  3 in total
  1 in total

Review 1.  A systematic review of the management of autonomic dysreflexia after spinal cord injury.

Authors:  Andrei Krassioukov; Darren E Warburton; Robert Teasell; Janice J Eng
Journal:  Arch Phys Med Rehabil       Date:  2009-04       Impact factor: 3.966
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.